Period tracking app allows women to order free NHS contraception

NHS-licensed healthcare platform Evaro has partnered with femtech startup Clue to provide access to NHS-funded contraception through the firm’s period-tracking app.

Through the integration Clue’s UK user base can order contraception through Evaro’s embedded pharmacy infrastructure, accessing free NHS-funded contraception with free delivery nationwide, offering a remote alternative to existing digital NHS services which are limited to specific postcodes.

The platform uses transparent dashboards which allows a remote experience, delivery, digital aftercare access, and re-ordering reminders.

Dr Thuria Wenbar, chief executive and co-founder of Evaro, said: “Nearly half of UK women can’t access basic contraception and I believe this is a systemic failure that technology can solve.

“This partnership with Clue represents what I call the ‘banking moment’ for healthcare. Just as we’d never queue at a bank to transfer £20 today, women shouldn’t wait two months for contraception.

“By providing this NHS service through our infrastructure in partnership with Clue, we’re transforming how hundreds of thousands of women can access reproductive healthcare in the future.

“Very much, I hope, with the level of convenience that online banking provides today.”

Users complete a brief online consultation on the Clue app before Evaro’s certified clinicians review and approve prescriptions.

Eligible patients in the UK will have access to 40 different NHS-funded oral contraception options, with medications are dispensed from Evaro’s GPhC-registered pharmacy and delivery the next day.

Rhiannon White, chief executive of Clue, said: “Our mission at Clue is to help women and people with cycles understand their bodies and take control of their health.

“By combining science and technology, we are actively changing the way people learn, access, and talk about menstrual and reproductive health around the world.

“Our partnership with Evaro is another step on that journey and we are delighted to be rolling out this innovative and convenient solution that will provide women with better access to prescription medication and greater agency over their wellbeing.”

Female-led firm Clue previously partnered with ŌURA, the company behind the Oura Ring, in 2023, to enable users to track their temperature more easily.

Meanwhile, researchers have called for greater regulation of period tracking apps, which they said may compromise users’ privacy and reproductive autonomy.

Meta was found liable by a Californian federal court for using sensitive personal data to run targeted ads, after Five women brought the class action law suit against Flo Health, Meta, Google and Flurry, alleging that their health data was shared by the app and used for advertising between 2016 and 2019.

Flo Health, which denied all of the claims, settled with the plaintiffs on 31 July 2025.

The firm became Europe’s first FemTech unicorn in July 2024 after raising more than $200 million in Series C investment.